Overview

• Subscribers pay £129 per month for once-weekly self-injectable tirzepatide pens aiming for about 20% body weight loss, with fees set to rise to £159 after the introductory offer.
• Morrisons Clinic delivers the service through online assessments by specially trained pharmacists, prescribers and clinicians who monitor patients’ medical history and progress each month.
• Shoppers have criticized the scheme as hypocritical for offering weight-loss treatments alongside the supermarket’s high-calorie food range.
• The private subscription runs alongside NHS pharmacy prescribing schemes launched this summer to broaden access to GLP-1 therapies.
• The MHRA has received over 560 pancreatitis reports and ten fatalities linked to GLP-1 injections and is investigating genetic risk factors via a collaboration with Genomics England.